COVID-19 and Depression

The COVID-19 pandemic embodies overwhelming stresses—unemployment, death, and isolation, among others. When called upon, clinicians must try to sort out demoralization from depression. This commentary discerns the characteristics of demoralization versus depression, and suggests solutions for both,...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical therapeutics Vol. 42; no. 6; pp. 962 - 963
Main Author:	Shader, Richard I.
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01-06-2020 Elsevier Limited
Subjects:	Anxiety - diagnosis Anxiety - psychology Betacoronavirus - pathogenicity Chloroquine Chloroquine - therapeutic use Coronavirus Infections - drug therapy Coronavirus Infections - epidemiology Coronavirus Infections - psychology Coronaviruses COVID-19 Demoralization Depression Depression - diagnosis Depression - psychology Humans Hydroxychloroquine Hydroxychloroquine - therapeutic use Mental depression Mental health Pandemics Pneumonia, Viral - drug therapy Pneumonia, Viral - epidemiology Pneumonia, Viral - psychology SARS-CoV-2 Unemployment - psychology COVID-19 Depression Hydroxychloroquine Chloroquine Demoralization
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The COVID-19 pandemic embodies overwhelming stresses—unemployment, death, and isolation, among others. When called upon, clinicians must try to sort out demoralization from depression. This commentary discerns the characteristics of demoralization versus depression, and suggests solutions for both, together with a cautionary word on the use chloroquine and hydroxychloroquine in patients with COVID-19.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0149-2918 1879-114X
DOI:	10.1016/j.clinthera.2020.04.010